ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,384Medicare Part D Prescriptions Filled, Including Refills

Rank: 317 out of 2343

$714K Total Retail Price of All Prescriptions

Rank: 311 out of 2343

983 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
61% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 983 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

7% of this provider’s 983 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

0% of this provider’s 10,423 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
WARFARIN SODIUM 575 492 1 8
SIMVASTATIN 469 439 2 1
LEVOTHYROXINE SODIUM 447 413 3 2
OMEPRAZOLE 358 285 4 4
LISINOPRIL 330 312 5 3
AMLODIPINE BESYLATE 295 273 6 5
DONEPEZIL HCL 262 262 7 21
ATORVASTATIN CALCIUM 252 239 8 10
FUROSEMIDE 248 225 9 6
HYDROCODONE-ACETAMINOPHEN 244 177 S3 10 13
NAMENDA 233 219 11 36
SERTRALINE HCL 196 159 12 20
METOPROLOL TARTRATE 193 171 13 7
CITALOPRAM HBR 189 165 14 17
POTASSIUM CHLORIDE 186 184 15 18
LANTUS 178 134 16 51
ATENOLOL 176 128 17 12
HYDROCHLOROTHIAZIDE 159 141 18 11
TAMSULOSIN HCL 151 137 19 29
PANTOPRAZOLE SODIUM 148 146 20 22
MIRTAZAPINE 140 137 21 41
METFORMIN HCL 138 87 22 9
OXYCODONE HCL 132 76 S2 23 67
TRAZODONE HCL 131 97 24 53
CARVEDILOL 124 124 25 27
CLOPIDOGREL 118 107 26 26
TRAMADOL HCL 106 93 27 25
ALLOPURINOL 100 76 28 31
QUETIAPINE FUMARATE 98 85 29 77
DIOVAN 95 87 30 23
CARBIDOPA-LEVODOPA 94 77 31 85
OXYCODONE-ACETAMINOPHEN 94 53 S2 31 49
ESCITALOPRAM OXALATE 89 73 33 55
GABAPENTIN 87 73 34 16
PLAVIX 86 75 35 38
KLOR-CON M20 86 63 35 44
ZOLPIDEM TARTRATE 85 69 37 24
NOVOLOG 80 77 38 110
POLYETHYLENE GLYCOL 3350 79 78 39 54
DIGOXIN 77 66 40 35
ALENDRONATE SODIUM 74 57 41 28
ADVAIR DISKUS 72 63 42 34
FENTANYL 70 30 S2 43 69
FAMOTIDINE 70 69 43 60
PRAVASTATIN SODIUM 69 59 45 15
SPIRIVA 69 63 45 48
LOSARTAN POTASSIUM 67 64 47 19
ISOSORBIDE MONONITRATE ER 65 63 48 32
SYNTHROID 63 52 49 40
PRANDIN 60 31 50 140
PAROXETINE HCL 58 56 51 66
HUMULIN R 58 44 51 269
CELEBREX 58 53 51 71
JANTOVEN 58 43 51 81
NEXIUM 57 35 55 33
FINASTERIDE 56 56 56 80
SPIRONOLACTONE 55 55 57 65
CLONIDINE HCL 54 39 58 70
EXELON 50 50 59 129
LEVETIRACETAM 50 50 59 104
DILTIAZEM 24HR CD 50 35 59 83
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 3, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.